← 產業報告目錄
Gene Transfer Technologies Market Size, Share & Trends Analysis Report, By Product (Instruments, Kits, & Assays, Consumables, Instruments, Others), By Mode (Viral Vector, Non-viral Vector and Physical Methods) By Method (In-Vivo, Ex-Vivo, In-vitro), Application, (Therapeutics, Research and Others), By End-user, By Region, Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-28頁數 180報告編號 INSIGHTACE-af95b7cbb1
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
In 2024, the Gene Transfer Technologies Market worldwide was assessed at USD 3.8 Bn. Analysts project it will develop to USD 10.1 Bn by 2034, at a CAGR of 10.7% spanning 2025 to 2034.
The Gene Transfer Technologies sector involves The market for gene transfer technologies (GTT) is the area of biotechnology that focuses on introducing genetic material into cells to improve biological processes, treat or prevent diseases, or incr. This domain has witnessed considerable transformation owing to technological breakthroughs and shifting healthcare dynamics.
Several factors contribute to this trajectory, including heightened appetite for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold considerable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and growing investment in the sector.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Gene Transfer Technologies Market Snapshot
Chapter 4. Global Gene Transfer Technologies Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Gene Transfer Technologies Market Industry Trends
4.10. Global Gene Transfer Technologies Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Gene Transfer Technologies Market Segmentation 1: By Product, Estimates & Trend Analysis
5.1. Market Share by Radioactive Product, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Radioactive Product:
5.2.1. Reagents, Kits, And Assays
5.2.2. Consumables
5.2.3. Instruments
5.2.4. Other Products
Chapter 6. Gene Transfer Technologies Market Segmentation 2: By Mode, Estimates & Trend Analysis
6.1. Market Share by Mode, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Mode:
6.2.1. Viral Vectors
6.2.1.1. Retroviruses
6.2.1.2. Adenoviruses
6.2.1.3. Adeno-Associated Viruses
6.2.1.4. Other Viral Vectors
6.2.2. Non-Viral Vectors
6.2.2.1. Chemical Methods
6.2.2.2. Liposome-Mediated
6.2.2.3. Calcium Phosphate
6.2.2.4. DEAE-Dextran
6.2.2.5. Cationic Polymers
6.2.2.6. Other Chemical Methods
6.2.3. Physical Methods
6.2.3.1. Electroporation
6.2.3.2. Microinjection
6.2.3.3. Gene Guns
6.2.3.4. Other Physical Methods
Chapter 7. Gene Transfer Technologies Market Segmentation 3: Method, Estimates & Trend Analysis
7.1. Market Share by Method, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Method:
7.2.1. In Vivo
7.2.2. Ex Vivo
7.2.3. In Vitro
Chapter 8. Gene Transfer Technologies Market Segmentation 4: By Application, Estimates & Trend Analysis
8.1. Market Share by Application, 2024 & 2034
8.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
8.2.1. Therapeutic Applications
8.2.1.1. Gene Therapy
8.2.1.2. Cell Therapy
8.2.1.3. Vaccines
8.2.1.4. Other Therapeutic Applications
8.2.2. Research Applications
8.2.2.1. Drug Discovery & Development
8.2.2.2. Infectious Diseases
8.2.2.3. Genetic & Neurological Disorders
8.2.2.4. Autoimmune Diseases
8.2.2.5. Other Diseases
8.2.2.6. Other Research Applications
8.2.3. Other Applications
Chapter 9. Gene Transfer Technologies Market Segmentation 5: By End-user, Estimates & Trend Analysis
9.1. Market Share by End-user, 2024 & 2034
9.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-user:
9.2.1. Pharmaceutical & Biotechnology Companies
9.2.2. Academic & Research Institutes
9.2.3. Other End Users
Chapter 10. Gene Transfer Technologies Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. Global Gene Transfer Technologies Market, Regional Snapshot 2024 & 2034
10.2. North America
10.2.1. North America Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.2.1.1. US
10.2.1.2. Canada
10.2.2. North America Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
10.2.3. North America Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by Mode, 2021-2034
10.2.4. North America Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by Method, 2021-2034
10.2.5. North America Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.2.6. North America Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
10.3. Europe
10.3.1. Europe Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.3.1.1. Germany
10.3.1.2. U.K.
10.3.1.3. France
10.3.1.4. Italy
10.3.1.5. Spain
10.3.1.6. Rest of Europe
10.3.2. Europe Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
10.3.3. Europe Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by Mode, 2021-2034
10.3.4. Europe Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by Method, 2021-2034
10.3.5. Europe Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.3.6. Europe Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
10.4. Asia Pacific
10.4.1. Asia Pacific Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.4.1.1. India
10.4.1.2. China
10.4.1.3. Japan
10.4.1.4. Australia
10.4.1.5. South Korea
10.4.1.6. Hong Kong
10.4.1.7. Southeast Asia
10.4.1.8. Rest of Asia Pacific
10.4.2. Asia Pacific Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
10.4.3. Asia Pacific Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by Mode, 2021-2034
10.4.4. Asia Pacific Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by Method, 2021-2034
10.4.5. Asia Pacific Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.4.6. Asia Pacific Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
10.5. Latin America
10.5.1. Latin America Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.5.1.1. Brazil
10.5.1.2. Mexico
10.5.1.3. Rest of Latin America
10.5.2. Latin America Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
10.5.3. Latin America Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by Mode, 2021-2034
10.5.4. Latin America Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by Method, 2021-2034
10.5.5. Latin America Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.5.6. Latin America Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
10.6. Middle East & Africa
10.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.6.1.1. GCC Countries
10.6.1.2. Israel
10.6.1.3. South Africa
10.6.1.4. Rest of Middle East and Africa
10.6.2. Middle East & Africa Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
10.6.3. Middle East & Africa Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by Mode, 2021-2034
10.6.4. Middle East & Africa Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by Method, 2021-2034
10.6.5. Middle East & Africa Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.6.6. Middle East & Africa Gene Transfer Technologies Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Thermo Fisher Scientific Inc.
11.2.1.1. Business Overview
11.2.1.2. Key Solution/Service Overview
11.2.1.3. Financial Performance
11.2.1.4. Geographical Presence
11.2.1.5. Recent Developments with Business Strategy
11.2.2. Danaher Corporation
11.2.3. Merck Kgaa
11.2.4. Bio-Rad Laboratories, Inc.
11.2.5. Agilent Technologies, Inc.
11.2.6. Revvity
11.2.7. Qiagen
11.2.8. Genscript
11.2.9. Takara Bio Inc.
11.2.10. Promega Corporation
11.2.11. Bio-Techne
11.2.12. Lonza
11.2.13. Oxford Biomedica Plc
11.2.14. Sartorius Ag
11.2.15. Maxcyte
11.2.16. Other prominent player
11.2.16.1. Cell Biolabs, Inc.
11.2.16.2. Gentarget Inc.
11.2.16.3. Origene Technologies, Inc.
11.2.16.4. Altogen Biosystems
11.2.16.5. OZ Biosciences
11.2.16.6. Genecopoeia, Inc.
11.2.16.7. Creative Biolabs
11.2.16.8. Synbio Technologies
11.2.16.9. System Biosciences
11.2.16.10. Vectorbuilder Inc.
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們